Article Details

FDA advisors unanimously back Lilly's Alzheimer's drug - BioProcess International

Retrieved on: 2024-06-11 15:42:17

Tags for this article:

Click the tags to see associated articles and topics

FDA advisors unanimously back Lilly's Alzheimer's drug - BioProcess International. View article details on hiswai:

Excerpt

The US FDA declined to grant the pharma giant's monoclonal antibody (mAb) for Alzheimer's disease (AD) accelerated approval in January 2023, but ...

Article found on: www.bioprocessintl.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up